{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T20:41:25Z","timestamp":1791664885370,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2012,9,1]],"date-time":"2012-09-01T00:00:00Z","timestamp":1346457600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinics in Laboratory Medicine"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1016\/j.cll.2012.06.004","type":"journal-article","created":{"date-parts":[[2012,6,22]],"date-time":"2012-06-22T22:15:08Z","timestamp":1340403308000},"page":"429-447","source":"Crossref","is-referenced-by-count":55,"title":["The Utility of Immunoassays for Urine Drug Testing"],"prefix":"10.1016","volume":"32","author":[{"given":"Stacy E.F.","family":"Melanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cll.2012.06.004_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S0009-8981(01)00714-8","article-title":"Urine drug screening in the medical setting","volume":"315","author":"Hammett-Stabler","year":"2002","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cll.2012.06.004_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.jpainsymman.2003.07.008","article-title":"Urine drug testing in pain medicine","volume":"27","author":"Heit","year":"2004","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.cll.2012.06.004_bib4","first-page":"1","article-title":"Opioid guidelines in the management of chronic non-cancer pain","volume":"9","author":"Trescot","year":"2006","journal-title":"Pain Physician"},{"key":"10.1016\/j.cll.2012.06.004_bib5","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1373\/49.3.357","article-title":"National academy of clinical biochemistry laboratory medicine practice guidelines: recommendations for the use of laboratory tests to support poisoned patients who present to the emergency department","volume":"49","author":"Wu","year":"2003","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2012.06.004_bib6","first-page":"136","article-title":"Drug abuse screening with immunoassays: unexpected cross-reactivities and other pitfalls","volume":"5","author":"Colbert","year":"1994","journal-title":"Br J Biomed Sci"},{"key":"10.1016\/j.cll.2012.06.004_bib7","first-page":"1","article-title":"False positive urine drug screens: what clinicians should know and when the laboratory should be consulted?","author":"Melanson","year":"2006","journal-title":"News Path"},{"key":"10.1016\/j.cll.2012.06.004_bib8","series-title":"Clinical toxicology testing: a guide for laboratory professionals","first-page":"83","article-title":"Analytical methodologies for the toxicology laboratory","author":"Rainey","year":"2012"},{"key":"10.1016\/j.cll.2012.06.004_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.forsciint.2005.03.022","article-title":"Drug screening and confirmation by GC-MS: comparison of EMIT II and Online KIMS against 10 drugs between US and England laboratories","volume":"157","author":"Lu","year":"2006","journal-title":"Forensic Sci Int"},{"key":"10.1016\/j.cll.2012.06.004_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/clinchem\/41.1.92","article-title":"Cloned enzyme donor immunoassay (CEDIA) for drugs-of-abuse screening","volume":"41","author":"Armbruster","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2012.06.004_bib11","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.cca.2011.01.029","article-title":"A new automated urine fentanyl immunoassay: technical performance and clinical utility for monitoring fentanyl compliance","volume":"412","author":"Snyder","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.cll.2012.06.004_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/jat\/bks003","article-title":"A new highly specific buprenorphine immunoassay for monitoring buprenorphine compliance and abuse","volume":"36","author":"Melanson","year":"2012","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.cll.2012.06.004_bib13","article-title":"Eye the basics, not baubles, for point-of-care testing","author":"Ford","year":"2010","journal-title":"CAP Today"},{"key":"10.1016\/j.cll.2012.06.004_bib14","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.2146\/ajhp090477","article-title":"Commonly prescribed medications and potential false-positive urine drug screens","volume":"67","author":"Brahm","year":"2010","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.cll.2012.06.004_bib15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/s00414-005-0544-x","article-title":"Cross-reactivity of the CEDIA buprenorphine assay with opiates: an Austrian phenomenon?","volume":"119","author":"Pavlic","year":"2005","journal-title":"Int J Legal Med"},{"key":"10.1016\/j.cll.2012.06.004_bib16","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1093\/clinchem\/33.6.1080","article-title":"Benzathine interference in the EMIT-st urine amphetamine assay","volume":"33","author":"Badcock","year":"1987","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2012.06.004_bib17","first-page":"549","article-title":"Mefenamic acid prevents assessment of drug abuse with EMIT assays","volume":"39","author":"Crane","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2012.06.004_bib18","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1093\/clinchem\/35.9.1998","article-title":"Ranitidine and high concentrations of phenylpropanolamine cross react in the EMIT monoclonal amphetamine\/methamphetamine assay","volume":"35","author":"Grinstead","year":"1989","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2012.06.004_bib19","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1093\/clinchem\/39.4.699","article-title":"Trimethobenzamide cross-reacts in immunoassays of amphetamine\/methamphetamine","volume":"39","author":"Jones","year":"1993","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2012.06.004_bib20","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1093\/clinchem\/36.7.1391a","article-title":"Ranitidine cross-reactivity in the EMIT d.a.u. Monoclonal Amphetamine\/Methamphetamine Assay","volume":"36","author":"Kelly","year":"1990","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2012.06.004_bib21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.5858\/2006-130-1834-RIBPIA","article-title":"Reduced interference by phenothiazines in amphetamine drug of abuse immunoassays","volume":"130","author":"Melanson","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cll.2012.06.004_bib22","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1016\/S0196-0644(05)80129-5","article-title":"Doxepin causing false-positive urine test for amphetamine","volume":"22","author":"Merigian","year":"1993","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cll.2012.06.004_bib23","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0196-0644(05)80433-0","article-title":"Desipramine and amantadine causing false-positive urine test for amphetamine","volume":"22","author":"Merigian","year":"1993","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.cll.2012.06.004_bib24","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1093\/clinchem\/41.6.955","article-title":"Bupropion metabolites produce false-positive urine amphetamine results","volume":"41","author":"Nixon","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2012.06.004_bib25","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/clinchem\/38.4.611","article-title":"Metabolites of chlorpromazine and brompheniramine may cause false-positive urine amphetamine results with monoclonal EMIT d.a.u. immunoassay","volume":"38","author":"Olsen","year":"1992","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2012.06.004_bib26","first-page":"369","article-title":"Buflomedil interference with the monoclonal EMIT d.a.u. amphetamine\/methamphetamine immunoassay","volume":"35","author":"Papa","year":"1997","journal-title":"Eur J Clin Chem Clin Biochem"},{"key":"10.1016\/j.cll.2012.06.004_bib27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1093\/jat\/15.2.101","article-title":"Ranitidine interference with the monoclonal EMIT d.a.u. amphetamine\/methamphetamine immunoassay","volume":"15","author":"Poklis","year":"1991","journal-title":"J Anal Toxicol"},{"key":"10.1016\/j.cll.2012.06.004_bib28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1081\/CLT-100103839","article-title":"False-positive amphetamine screen following a trazodone overdose","volume":"39","author":"Roberge","year":"2001","journal-title":"J Toxicol Clin Toxicol"},{"key":"10.1016\/j.cll.2012.06.004_bib29","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1093\/clinchem\/42.10.1725","article-title":"False-positive results for urine amphetamine and opiate immunoassays in a patient intoxicated with perazine","volume":"42","author":"Schmolke","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2012.06.004_bib30","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/clinchem\/41.6.951","article-title":"False-positive results with Emit II amphetamine\/methamphetamine assay in users of common psychotropic drugs","volume":"41","author":"Smith-Kielland","year":"1995","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2012.06.004_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/clinchem\/40.6.948","article-title":"Possible explanation for trimethobenzamide cross-reaction in immunoassays of amphetamine\/methamphetamine","volume":"40","author":"Colbert","year":"1994","journal-title":"Clin Chem"},{"key":"10.1016\/j.cll.2012.06.004_bib32","doi-asserted-by":"crossref","first-page":"735","DOI":"10.5858\/134.5.735","article-title":"Interpretation and utility of drug of abuse immunoassays: lessons from laboratory drug testing surveys","volume":"134","author":"Melanson","year":"2010","journal-title":"Arch Pathol Lab Med"}],"container-title":["Clinics in Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271212000753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0272271212000753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T10:24:00Z","timestamp":1642587840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0272271212000753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["S0272271212000753"],"URL":"https:\/\/doi.org\/10.1016\/j.cll.2012.06.004","relation":{},"ISSN":["0272-2712"],"issn-type":[{"value":"0272-2712","type":"print"}],"subject":[],"published":{"date-parts":[[2012,9]]}}}